Clinical Decision Support for Women With a History of Gestational Diabetes
|ClinicalTrials.gov Identifier: NCT01288144|
Recruitment Status : Completed
First Posted : February 2, 2011
Last Update Posted : February 6, 2012
The investigators hypothesize that computer-assisted decision support will increase the percentage of women with a history of gestational diabetes who receive appropriate follow-up screening.
Specific Aim 1: Develop an algorithm to identify cases of gestational diabetes among patients in the Partners Health Care system using administrative and laboratory data.
Specific Aim 2: Assess primary care provider knowledge, attitudes, beliefs, and barriers to compliance regarding screening guidelines for women with a history of gestational diabetes.
Specific Aim 3: Test whether a computer-assisted decision support tool to identify patients with a GDM history and prompt screening will increase compliance with guidelines. The investigators hypothesize that decision support will significantly increase in the percentage of women screened.
|Condition or disease||Intervention/treatment|
|Gestational Diabetes Mellitus||Other: Quality improvement initiative|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1000 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Clinical Decision Support for Women With a History of Gestational Diabetes|
|Study Start Date :||July 2007|
|Primary Completion Date :||November 2011|
Quality improvement initiative using computerized decision support
Other: Quality improvement initiative
In intervention clinics, the LMR will use the existing reminder function to alert providers that a patient has a probable history of gestational diabetes. The provider will then have the opportunity to clarify the subject's history and order appropriate screening testing. Providers will also have access to online reference material regarding GDM follow-up screening and lifestyle interventions.
Other Name: Quality improvement initiative using computerized decision support
No Intervention: Usual care
In control clinics, women will continue to receive usual care.
- Rate of screening [ Time Frame: 1 year following implementation at all sites (Nov. 2011) ]
The American Diabetes Association recommends that women with a history of GDM undergo glucose screening at 6 weeks post partum. Women with normal postpartum glucose testing should receive follow-up testing every three years, and those with impaired glucose tolerance should receive annual follow-up screening.
Our study will evaluate a quality improvement intervention to increase the number of women who are appropriately identified and undergo screening.